Los Angeles, CA, United States of America

Santosh Peddi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Southern California. Active years: 2022-2025.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Santosh Peddi in Protein Delivery Systems.

Introduction

Santosh Peddi is an accomplished inventor based in Los Angeles, CA. He has made significant contributions to the field of protein delivery systems, particularly through his innovative work at the University of Southern California. With a total of 2 patents, his research focuses on enhancing the delivery of therapeutic agents.

Latest Patents

Santosh Peddi's latest patents include the development of multimeric elastin-like polypeptides. This disclosure provides novel compositions and methods to deliver cyclosporine A using genetically engineered protein polymers. His work in this area aims to improve the efficacy and safety of drug delivery systems.

Career Highlights

Throughout his career, Santosh has demonstrated a commitment to advancing scientific knowledge and practical applications in biotechnology. His role at the University of Southern California has allowed him to collaborate with leading researchers and contribute to groundbreaking studies.

Collaborations

Some of his notable coworkers include John Andrew Mackay and Mihir Shah. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Santosh Peddi's work exemplifies the intersection of innovation and practical application in the field of protein delivery systems. His contributions continue to pave the way for advancements in therapeutic delivery methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…